PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OAB
Axonics, Inc. · NCT06789406
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Not accepted (a condition is required)
- Study type
- Interventional · Not applicable
- Target enrollment
- 55
- US sites recruiting
- 2
- Study start
- September 18, 2025
- Record last updated
- October 13, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Post-market clinical follow-up for continued assessment of safety and performance to confirm long-term outcomes of the Axonics SNM System INS Model 5101.
Being studied: Axonics SNM System INS Model 5101 (R20)
Conditions: Urinary Urge Incontinence (UUI); Urinary Frequency (UF); Overactive Bladder (OAB)
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- 18 years or older
- Primary indication of OAB (urinary urgency incontinence (UUI) / urinary frequency (UF) who are not candidates for, or who have failed conservative treatment
- Willing and capable to provide written consent and agrees to comply with specified evaluations at clinical centers for all follow-up assessments
Exclusion Criteria
- Any significant medical condition that is likely to interfere with procedures, device operation, or likely to confound evaluation of endpoints (i.e., neurological conditions such as multiple sclerosis)
- Any psychiatric or personality disorder that is likely to interfere with procedures at the discretion of the participating physician; this may include poor understanding or compliance with requirements
- Previously underwent an external sacral neuromodulation SNM trial and was deemed a non-responder or was previously implanted with a sacral neuromodulation device and did not get therapeutic benefit (a non-responder)
- History of allergic response to titanium, zirconia, polyurethane, epoxy, or silicone
- A female who is breastfeeding
- A female with a positive urine pregnancy test
Recruiting US locations
University of Chicago
Chicago, IL 60637
Site contact: Rowena Shi
University of Missouri
Columbia, MO 65211
Site contact: Kaycee Mackanos
Study contacts (from the official record)
- Caroline Beaudoint · +32479904163 · Caroline.Beaudoint@bsci.com
- Erum Shaikh · 657-626-4310 · Erum.Shaikh@bsci.com
Similar studies in Illinois
All women’s health studies in Illinois →- Recruiting
A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)
Valencia Technologies Corporation
- Location
- Chicago, IL + 18 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.
Granata Bio Corporation
- Location
- Chicago, IL + 14 other US sites
- Eligibility basics
- Ages 18–42 · Women only
- Recruiting
Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)
FemPulse Corporation
- Location
- Barrington, IL + 11 other US sites
- Eligibility basics
- Ages 21+ · Women only
- Recruiting
Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)
Coologics, Inc
- Location
- Chicago, IL + 7 other US sites
- Eligibility basics
- Ages 22–49 · Women only